Target intelligence / Profile preview

Human serum albumin and plasma lipoproteins

Molecular classification
Transport protein, Plasma protein, Lipoprotein complex, Apolipoprotein
01

Overview

Human serum albumin (HSA) and plasma lipoproteins are the principal transport components of human blood, collectively responsible for the distribution of lipids, hormones, and xenobiotics. HSA is a monomeric protein that maintains plasma oncotic pressure and provides significant buffering capacity while binding a diverse array of ligands, including many acidic drugs (StatPearls, 2023). Plasma lipoproteins are multicomponent aggregates of lipids and specialized proteins (apolipoproteins) that facilitate the transport of hydrophobic cholesterol and triglycerides between tissues (NIH, 2022). In pharmacology, these entities are critical determinants of drug half-life and volume of distribution, as only the unbound fraction of a drug is typically pharmacologically active (PubMed, 2021). While they are not usually the primary targets of drug action, their levels and binding affinities are vital considerations in therapeutic dosing and the management of metabolic diseases like atherosclerosis (UniProt, 2024).

Other names
Plasma proteinsBlood transport proteinsSerum albuminLipoprotein particlesALBChylomicronsVLDLLDLHDL
02

Mechanism of action

These entities primarily function as transport vehicles rather than receptors; drugs interact via reversible binding to specific hydrophobic pockets (e.g., Sudlow sites I and II on albumin) or by being incorporated into the lipid core of lipoprotein particles for systemic distribution (PubMed, 2021).

03

Biological functions

Transport of hydrophobic moleculesMaintenance of oncotic pressureLipid metabolismpH bufferingLigand binding and sequestrationAntioxidant activity
04

Disease associations

AtherosclerosisHypoalbuminemiaHyperlipidemiaCardiovascular diseaseLiver cirrhosisNephrotic syndrome
05

Safety considerations

Competitive displacement leading to increased free drug fraction and toxicityAltered pharmacokinetics in patients with liver or kidney dysfunctionRisk of cardiovascular events associated with high LDL/low HDL ratiosDrug-drug interactions due to shared protein binding sites
06

Interacting drugs

Warfarin

6 more in the full profile.

07

Biomarkers

Serum albumin concentrationLow-density lipoprotein cholesterol (LDL-C)High-density lipoprotein cholesterol (HDL-C)Apolipoprotein B (ApoB)Total cholesterol

Beyond the preview

Go deeper on Human serum albumin and plasma lipoproteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human serum albumin and plasma lipoproteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call